COMPARISON OF THE INACTIVATION OF IGM AND IGG COMPLEMENT FIXATION SITES BY ACID AND BASE.DAVID STOLLAR B; STADECKER MJ; MORECKI S et al.1976; J. IMMUNOL.; U.S.A.; DA. 1976; VOL. 117; NO 4; PP. 1387-1391; BIBL. 32 REF.Article

THE ROLE OF THE SPLEEN IN TUMOR GROWTH KINETICS OF THE MURINE B CELL LEUKEMIA (BCL₁)SLAVIN S; MORECKI S; WEISS L et al.1980; J. IMMUNOL.; USA; DA. 1980; VOL. 124; NO 2; PP. 586-589; BIBL. 14 REF.Article

SPECIFIC-INTERACTIONS OF ANTIGEN WITH CELLS STUDIED BY MEANS OF ROSETTE-FORMATIONSULITZEANU D; MORECKI S; NAOR D et al.1974; ISRAEL J. MED. SCI.; ISRAEL; DA. 1974; VOL. 10; NO 11; PP. 1397-1404; BIBL. 17 REF.Article

ERADICATION OF MURINE LEUKEMIA WITH HISTOINCOMPATIBLE MARROW GRAFTS IN MICE CONDITIONED WITH TOTAL LYMPHOID IRRADIATION (TLI)SLAVIN S; WEISS L; MORECKI S et al.1981; CANCER IMMUNOL. IMMUNOTHER.; ISSN 0340-7004; DEU; DA. 1981; VOL. 11; NO 2; PP. 155-158; BIBL. 12 REF.Article

SUPPRESSION AND ELIMINATION OF BCL₁ LEUKEMIA BY ALLOGENEIC BONE MARROW TRANSPLANTATION = SUPPRESSION ET ELIMINATION DE LA LEUCEMIE BCL1 PAR GREFFE ALLOGENIQUE DE MOELLE OSSEUSEWEISS L; MORECKI S; VITETTA ES et al.1983; JOURNAL OF IMMUNOLOGY; ISSN 0022-1767; USA; DA. 1983; VOL. 130; NO 5; PP. 2452-2455; ABS. ENG; BIBL. 13 REF.; GRAPHArticle

Combination of magnetic and chemocytotoxic cancer cell depletion for autologous bone marrow transplantationMORECKI, S; SLAVIN, S.Israel journal of medical sciences. 1988, Vol 24, Num 9-10, pp 488-493, issn 0021-2180Article

LONG-TERM ENZYME REPLACEMENT THERAPY IN BETA -GLUCURONIDASE-DEFICIENT MICE BY ALLOGENEIC BONE MARROW TRANSPLANTATIONYATZIN S; WEISS L; MORECKI S et al.1982; J. LAB. CLIN. MED.; ISSN 0022-2143; USA; DA. 1982; VOL. 99; NO 6; PP. 792-797; BIBL. 28 REF.Article

ULTRASTRUCTURAL, CELL MEMBRANE, AND CYTOGENETIC CHARACTERISTICS OF B-CELL LEUKEMIA, A MURINE MODEL OF CHRONIC LYMPHOCYTIC LEUKEMIASLAVIN S; WEISS L; MORECKI S et al.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 10; PP. 4162-4166; BIBL. 28 REF.Article

The use of soybean agglutinin (SBA) for bone marrow (BM) purging and hematopoietic progenitor cell enrichment in clinical bone-marrow transplantationNAGLER, A; MORECKI, S; SLAVIN, S et al.Molecular biotechnology. 1999, Vol 11, Num 2, pp 181-194, issn 1073-6085Article

Allogeneic cell therapy for a murine mammary carcinomaMORECKI, S; YACOVLEV, E; DIAB, A et al.Cancer research (Baltimore). 1998, Vol 58, Num 17, pp 3891-3895, issn 0008-5472Article

Removal of breast cancer cells by soybean agglutinin in an experimental model for purging human marrowMORECKI, S; MARGEL, S; SLAVIN, S et al.Cancer research (Baltimore). 1988, Vol 48, Num 16, pp 4573-4577, issn 0008-5472, 5 p.Article

Alloantigen persistence in induction and maintenance of transplantation toleranceMORECKI, S; LESHEM, B; EID, A et al.The Journal of experimental medicine. 1987, Vol 165, Num 6, pp 1468-1480, issn 0022-1007Article

Lectin separation of nonlymphoid suppressor cells induced by total lymphoid irradiationMORECKI, S; WEIGENSBERG, M; SLAVIN, S et al.European journal of immunology. 1985, Vol 15, Num 2, pp 138-148, issn 0014-2980Article

Proliferative response of murine B-cell leukemia (BCL₁) to poly(L-lysine)MORECKI, S; FLECHNER, Y; SLAVIN, S et al.Cellular immunology (Print). 1985, Vol 90, Num 2, pp 392-400, issn 0008-8749Article

Effect of indomethacin on tumorigenicity and immunity induction in a murine model of mammary carcinomaMORECKI, S; YACOVLEV, L; SLAVIN, S et al.International journal of cancer. 1998, Vol 75, Num 6, pp 894-899, issn 0020-7136Article

Induction of tumor immunity by intact irradiated leukemic B cells (BCL1) bearing a tumor-associated cell-surface idiotype and the costimulatory B7 moleculeMORECKI, S; LEVI, S; PUYESKY, Y et al.Cancer immunology and immunotherapy. 1995, Vol 41, Num 4, pp 236-242, issn 0340-7004Article

Cytokine gene transduction into non-immunogeneic murine tumor cellsMORECKI, S; LUBINA-SALOMON, A; SLAVIN, S et al.Cytokines, cellular & molecular therapy. 1998, Vol 4, Num 2, pp 87-94, issn 1368-4736Article

The effect of in vitro T lymphocyte depletion on generation of IL2-activated cytotoxic cellsMORECKI, S; NABET, C; ACKERSTEIN, A et al.Bone marrow transplantation (Basingstoke). 1991, Vol 7, Num 4, pp 269-273, issn 0268-3369, 5 p.Article

Functional clonal deletion versus suppressor cell-induced transplantation tolerance in chimeras prepared with a short course of total-lymphoid irradiationSLAVIN, S; MORECKI, S; WEIGENSBERG, M et al.Transplantation. 1986, Vol 41, Num 6, pp 680-687, issn 0041-1337Article

Resistance to mycobacteria in mice treated with fractionated total lymphoid irradiation (TLI) and in mice reconstituted with allogeneic bone marrow cells following radiotherapyMOR, N; LUTSKY, I; WEISS, L et al.International journal of radiation oncology, biology, physics. 1985, Vol 11, Num 1, pp 79-85, issn 0360-3016Article

Functional clonal deletion versus active suppression in transplantation tolerance induced by total-lymphoid irradiationMORECKI, S; LESHEM, B; WEIGENSBERG, M et al.Transplantation. 1985, Vol 40, Num 2, pp 201-210, issn 0041-1337Article

Induction of graft vs. tumor effect in a murine model of mammary adenocarcinomaMORECKI, S; MOSHELI, Y; GELFEND, Y et al.International journal of cancer. 1997, Vol 71, Num 1, pp 59-63, issn 0020-7136Article

Immunotherapy of relapsed resistant chronic myelogenous leukemia post allogeneic bone marrow transplantation with alloantigen pulsed donor lymphocytesSLAVIN, S; ACKERSTEIN, A; MORECKI, S et al.Bone marrow transplantation (Basingstoke). 2001, Vol 28, Num 8, pp 795-798, issn 0268-3369Article

Suppression of cell-mediated immune responses after total lymphoid irradiation (TLI). I: Characterization of suppressor cells of the mixed lymphocyte reactionWEIGENSBERG, M; MORECKI, S; WEISS, L et al.The Journal of immunology (1950). 1984, Vol 132, Num 2, pp 971-978, issn 0022-1767Article

Tumor-cell vaccination induces tumor dormancy in a murine model of B-cell leukemia/lymphoma (BCL₁)MORECKI, S; PUGATSCH, T; LEVI, S et al.International journal of cancer. 1996, Vol 65, Num 2, pp 204-208, issn 0020-7136Article